Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model [Phase 2]
Phase 2 neoadjuvant therapy trial for resectable hepatocellular carcinoma is actively recruiting, employing a multimodal deep learning model…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating the combination of cabozantinib with ipilimumab/nivolumab and transarterial chemoembolization (TACE) for…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
A clinical trial at West China Hospital is recruiting patients with hepatocellular carcinoma undergoing right hemihepatectomy to evaluate te…
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis [Phase 3]
Phase 3 trial of Namodenoson for advanced hepatocellular carcinoma in patients with Child-Pugh B7 cirrhosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
The clinical trial NCT01349075 evaluating TheraSphere for unresectable hepatocellular carcinoma has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT [Phase 2]
Phase 2 trial evaluating lenvatinib plus sintilimab with or without DEB-TACE and hepatic arterial infusion chemotherapy for non-resectable h…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Blood Sample Collection for Experimental Blood Test to Track Liver Cancer
A completed clinical trial update describing blood sample collection for an experimental blood test to monitor hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2025-04-29Clinical Trial Update: Lenvatinib Plus SIRT vs Lenvatinib in TACE-Refractory HCC [Phase 2]
A Phase 2 trial comparing lenvatinib plus selective internal radiation therapy (SIRT) versus lenvatinib alone in patients with TACE-refracto…
-
CLINICAL_TRIALS withdrawal · 2025-04-27Clinical Trial Update: A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma [Phase 2]
A Phase II study of ABC294640 as monotherapy in advanced hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma [EARLY_Phase 1]
An early-phase trial evaluating the safety and efficacy of CD-801 in patients with advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Implication of Long Non-coding RNA HOTTIP Haplotype on Liver Cancer Metastasis
A completed clinical trial update investigates whether the haplotype of the long non-coding RNA HOTTIP influences metastasis in hepatocellul…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
A clinical trial is evaluating a Raman spectroscopy-based deep learning model for early cancer diagnosis; recruitment is ongoing. The study …
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients [EARLY_Phase 1]
A clinical trial update for an early-phase study evaluating intravenous CD-801 in patients with advanced hepatocellular carcinoma, currently…
-
CLINICAL_TRIALS research · 2025-04-23Clinical Trial Update: Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive Tumors
A real-world study evaluating nano-crystalline megestrol acetate for cachexia in patients with advanced digestive tumors is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Radioembolization as a Spearhead Treatment of Hepatocellular Carcinoma With Localized Portal Vein Tumor Thrombosis [Phase 2]
A Phase 2 clinical trial is evaluating radioembolization as a spearhead treatment for hepatocellular carcinoma with localized portal vein tu…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: Relationship Between FGF19 Overexpression and Disease Prognosis
The trial examines whether FGF19 overexpression influences prognosis in hepatocellular carcinoma. Recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular Cancer [Phase 2]
Phase 2 study evaluating SHR-1826 as monotherapy or in combination with immunotherapy for advanced hepatocellular carcinoma; currently not y…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Microbiota Study in Liver Transplanted Patients
A microbiota-focused clinical trial in patients with cirrhosis and hepatocellular carcinoma undergoing liver transplantation has completed.
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF
This clinical trial update describes the CHIEF study in France examining how social determinants of health influence the management of hepat…
-
CLINICAL_TRIALS trial_result · 2025-04-20Clinical Trial Update: Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial evaluating Ezurpimtrostat with atezolizumab-bevacizumab as first-line therapy for unresectable hepatocellular carcinoma has …
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma [Phase 2]
Phase 2 open-label study of ENMD-2076 in patients with advanced fibrolamellar hepatocellular carcinoma and advanced hepatocellular carcinoma…
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Predictive Value of Albumin - Bilirubin Score and CRP - Albumin - Lymphocyte Index for HCC Prognosis After Radical Resection
A clinical trial update evaluating whether the albumin-bilirubin score and CRP-albumin-lymphocyte index can predict prognosis after radical …
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting
This clinical trial update examines the real-world epidemiology of patients treated with the atezolizumab and bevacizumab combination for he…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk [Phase 4]
This document reports an ongoing Phase 4 clinical trial of AK112, a PD-1/VEGF bispecific antibody, for resectable hepatocellular carcinoma w…
-
CLINICAL_TRIALS trial_result · 2025-04-15Clinical Trial Update: Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis [Phase 2]
Phase 2 trial evaluating simvastatin to prevent hepatocellular carcinoma in patients with liver cirrhosis; results have been posted and the …